136 related articles for article (PubMed ID: 19078467)
1. Malignant neoplasms in autoimmune rheumatic diseases: examination of the risk of developing a malignancy among five different rheumatic diseases in one institution.
Villa AR; Kraus A; Jiménez-Corona A; Sandino S; Velázquez-González A; Granados J; Alarcón-Segovia D
J Clin Rheumatol; 2000 Aug; 6(4):176-83. PubMed ID: 19078467
[TBL] [Abstract][Full Text] [Related]
2. Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study.
Hsu CY; Ko CH; Wang JL; Hsu TC; Lin CY
Arthritis Res Ther; 2019 Oct; 21(1):211. PubMed ID: 31604447
[TBL] [Abstract][Full Text] [Related]
3. Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
Chen HH; Chao WC; Liao TL; Lin CH; Chen DY
PLoS One; 2018; 13(7):e0201340. PubMed ID: 30048527
[TBL] [Abstract][Full Text] [Related]
4. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.
Wang HL; Zhou YM; Zhu GZ; Yang Z; Hua BJ
Clin Rheumatol; 2018 Jan; 37(1):81-85. PubMed ID: 28508950
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.
Hsu HC; Chang YS; Hou TY; Chen LF; Hu LF; Lin TM; Chiou CS; Tsai KL; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Clin Rheumatol; 2021 Sep; 40(9):3755-3763. PubMed ID: 33646447
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigens class II genes are associated with cancer development in the autoimmune rheumatic diseases.
Miranda-Duarte A; Kraus-Weisman A; Granados J; Vill AR
Rev Invest Clin; 2011; 63(3):236-43. PubMed ID: 21888287
[TBL] [Abstract][Full Text] [Related]
9. Association Between a History of Dengue Fever and the Risk of Systemic Autoimmune Rheumatic Diseases: A Nationwide, Population-Based Case-Control Study.
Chen YW; Hsieh TY; Lin CH; Chen HM; Lin CC; Chen HH
Front Med (Lausanne); 2021; 8():738291. PubMed ID: 34805205
[No Abstract] [Full Text] [Related]
10. Incidence and Risk Factors of Mental Illnesses Among Patients with Systemic Autoimmune Rheumatic Diseases: An 18-year population-based study.
Chu WM; Chao WC; Chen DY; Ho WL; Chen HH
Rheumatology (Oxford); 2024 Apr; ():. PubMed ID: 38579187
[TBL] [Abstract][Full Text] [Related]
11. [Cyclophosphamide pulse therapy for refractory rheumatic diseases].
Tateishi M; Taniguchi A; Moriguchi M; Hara M; Kashiwazaki S
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Jun; 20(3):152-8. PubMed ID: 9256607
[TBL] [Abstract][Full Text] [Related]
12. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
Sahin M; Aydintug O; Tunc SE; Tutkak H; Naziroğlu M
Clin Biochem; 2007 Jan; 40(1-2):6-10. PubMed ID: 17056024
[TBL] [Abstract][Full Text] [Related]
13. Association of systemic and thyroid autoimmune diseases.
Biró E; Szekanecz Z; Czirják L; Dankó K; Kiss E; Szabó NA; Szucs G; Zeher M; Bodolay E; Szegedi G; Bakó G
Clin Rheumatol; 2006 Mar; 25(2):240-5. PubMed ID: 16247581
[TBL] [Abstract][Full Text] [Related]
14. Rheumatic diseases and malignancy--is there an association?
Leandro MJ; Isenberg DA
Scand J Rheumatol; 2001; 30(4):185-8. PubMed ID: 11578009
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary pathology of the rheumatic diseases.
Leslie KO; Trahan S; Gruden J
Semin Respir Crit Care Med; 2007 Aug; 28(4):369-78. PubMed ID: 17764055
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against C-reactive protein (CRP) in sera of patients with systemic rheumatic diseases.
Minatani M; Aotsuka S; Satoh T
Mod Rheumatol; 2001 Jun; 11(2):127-31. PubMed ID: 24383688
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases.
Nozawa K; Kayagaki N; Tokano Y; Yagita H; Okumura K; Hasimoto H
Arthritis Rheum; 1997 Jun; 40(6):1126-9. PubMed ID: 9182923
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP
Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103
[TBL] [Abstract][Full Text] [Related]
19. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases.
Yang Z; Zhang Z; Lin F; Ren Y; Liu D; Zhong R; Liang Y
APMIS; 2017 Oct; 125(10):863-871. PubMed ID: 28766758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
